The table below shows Autolus Therapeutics plc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$75.39M
$10.12M
$1.70M
-
-
-
Cost of revenue
$96.37M
$11.39M
$0.00
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$117.69M
$138.44M
$130.48M
$117.35M
$110.84M
$134.89M
SG&A
$131.87M
AUTL annual revenue (10-K history)
Autolus Therapeutics plc reported annual revenue of $75.39M for fiscal year 2025. That is up 644.9% from $10.12M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $1.21M (FY 2016) to $75.39M. Figures come from the company's audited annual reports as filed with the SEC.